Scientists have welcomed a “truly wonderful” new drug for a hard-to-treat and aggressive form of cancer.
Researchers led by a team at Queen Mary University of London said their new treatment “quadrupled” three-year survival rates and increased average survival by 1.6 months.
Academics said that the new drug, which works by cutting off the tumour ’s food supply, is the first of its type for mesothelioma in 20 years.
Comments are closed.